|
|
Volumn 19, Issue 5, 1998, Pages 303-308
|
|
Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with alloxan-induced diabetes mellitus
a
|
|
Author keywords
DA 1131; Diabetes mellitus; Pharmacokinetics; Tissue distribution
|
|
Indexed keywords
2 (3 METHANSULFONYLAMINO 1 PROPENYL)PYRROLIN 4 YLTHIOL 6 (1 HYDROXYETHYL) 1 METHYL 1 CARBAPEN 2 EM 3 CARBOXYLIC ACID;
CARBAPENEM DERIVATIVE;
UNCLASSIFIED DRUG;
ALLOXAN DIABETES MELLITUS;
ANIMAL EXPERIMENT;
AREA UNDER THE CURVE;
ARTICLE;
DIABETIC NEPHROPATHY;
DOSE KIDNEY FUNCTION RELATION;
DRUG ABSORPTION;
DRUG CLEARANCE;
DRUG METABOLISM;
GLOMERULUS FILTRATION RATE;
LIVER METABOLISM;
NONHUMAN;
RAT;
ALLOXAN;
ANIMALS;
CARBAPENEMS;
DIABETES MELLITUS, EXPERIMENTAL;
INJECTIONS, INTRAVENOUS;
METABOLIC CLEARANCE RATE;
RATS;
RATS, SPRAGUE-DAWLEY;
TISSUE DISTRIBUTION;
|
|
EID: 0031809814
PISSN: 01422782
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1099-081X(199807)19:5<303::AID-BDD103>3.0.CO;2-5 Document Type: Article |
|
Times cited : (22)
|
|
References (19)
|
